Sanofi Share Price London S.E.

Equities

0O59

FR0000120578

Pharmaceuticals

Real-time Estimate Tradegate 14:15:31 03/07/2024 BST 5-day change 1st Jan Change
90.32 EUR -0.51% Intraday chart for Sanofi -0.30% +1.10%

Financials

Sales 2024 * 46.33B 49.91B 3,925B Sales 2025 * 49.75B 53.61B 4,215B Capitalization 113B 122B 9,579B
Net income 2024 * 7.07B 7.61B 599B Net income 2025 * 8.57B 9.24B 726B EV / Sales 2024 * 2.59 x
Net Debt 2024 * 6.96B 7.5B 590B Net Debt 2025 * 2.53B 2.72B 214B EV / Sales 2025 * 2.32 x
P/E ratio 2024 *
16.3 x
P/E ratio 2025 *
13.3 x
Employees 86,088
Yield 2024 *
4.28%
Yield 2025 *
4.5%
Free-Float 87.13%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.50%
1 week-0.30%
Current month+0.69%
1 month+0.63%
3 months+1.99%
6 months-1.27%
Current year+1.10%
More quotes
1 week
89.32
Extreme 89.32
92.41
1 month
85.95
Extreme 85.95
93.02
Current year
84.71
Extreme 84.71
96.48
1 year
80.62
Extreme 80.62
104.70
3 years
75.61
Extreme 75.609
106.64
5 years
65.86
Extreme 65.8612
106.64
10 years
62.99
Extreme 62.99
106.64
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 31/08/19
Chief Operating Officer 40 31/12/21
Chief Tech/Sci/R&D Officer 51 -
Members of the board TitleAgeSince
Director/Board Member 70 30/04/14
Director/Board Member 62 27/04/20
Director/Board Member 64 21/05/20
More insiders
Date Price Change Volume
03/07/24 90.68 -0.11% 240
02/07/24 91.02 -0.52% 207,682
01/07/24 91.5 +1.60% 3,218,056
28/06/24 90.06 -0.07% 844,415
27/06/24 90.12 -0.92% 79,061

Delayed Quote London S.E., July 03, 2024 at 12:37 pm

More quotes
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
90.44 EUR
Average target price
108.1 EUR
Spread / Average Target
+19.52%
Consensus